Document Detail


Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart.
MedLine Citation:
PMID:  7923616     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Evidence is presented that heparin pretreatment produces protective effects on myocardial tissue distinct from its anticoagulant activity. The present study examines the ability of heparin sulfate and N-acetyl heparin (a derivative of heparin devoid of anticoagulant effects) to protect the heart from injury associated with global ischemia and reperfusion. Male New Zealand White rabbits were administered either heparin sulfate (n = 7, 300 U/kg i.v.), N-acetyl heparin (n = 6, 1.73 mg/kg i.v.), or vehicle (n = 6). Two hours after treatment, the hearts were removed, perfused on a Langendorff apparatus, and subjected to 30 minutes of global ischemia, followed by 45 minutes of reperfusion. During reperfusion, creatine kinase concentrations in the coronary sinus effluent were greater in hearts from vehicle-treated rabbits compared with hearts from N-acetyl heparin-treated and heparin-treated rabbits. Left ventricular end-diastolic pressure after 45 minutes of reperfusion in the vehicle-treated group was 64 +/- 15 mm Hg compared with 17 +/- 4 and 10 +/- 3 mm Hg in the heparin-pretreated and N-acetyl heparin-pretreated groups, respectively. Heparin, but not N-acetyl heparin, increased the activated partial thromboplastin time, consistent with its known anticoagulant action. Heparin and N-acetyl heparin inhibited complement-mediated erythrocyte lysis in a concentration-dependent manner. The glycosaminoglycans, in contrast to r-hirudin, reduced complement activation-induced injury in the rabbit isolated heart. The results demonstrate that heparin or N-acetyl heparin, administered to the intact rabbit, protects the isolated heart from subsequent myocardial dysfunction secondary to ischemia/reperfusion. The cardioprotective effects of heparin and N-acetyl heparin are independent of an antithrombin mechanism.
Authors:
G S Friedrichs; K S Kilgore; P J Manley; M R Gralinski; B R Lucchesi
Related Documents :
20660806 - First clinical application of an actively reversible direct factor ixa inhibitor as an ...
18349026 - Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after...
12783606 - Evolving role of bivalirudin in percutaneous coronary interventions; impact of the repl...
12360156 - Low-molecular-weight heparin therapy for non-st-elevation acute coronary syndromes and ...
19553746 - Misleading ecg appearance of av block due to concealed av nodal conduction caused by in...
8878006 - Intravenous magnesium sulphate and reperfused myocardium: preservation of function and ...
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Circulation research     Volume:  75     ISSN:  0009-7330     ISO Abbreviation:  Circ. Res.     Publication Date:  1994 Oct 
Date Detail:
Created Date:  1994-10-26     Completed Date:  1994-10-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0047103     Medline TA:  Circ Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  701-10     Citation Subset:  IM    
Affiliation:
University of Michigan Medical School, Department of Pharmacology, Ann Arbor 48109-0626.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Calcium / metabolism
Creatine Kinase / blood
Glycosaminoglycans / metabolism
Heart / drug effects*
Hemodynamics
Heparin / analogs & derivatives*,  pharmacology*
Male
Myocardial Ischemia* / physiopathology
Myocardial Reperfusion Injury / prevention & control*
Myocardium / metabolism
Partial Thromboplastin Time
Rabbits
Time Factors
Grant Support
ID/Acronym/Agency:
HL-19782-15/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Glycosaminoglycans; 134498-62-7/N-acetylheparin; 7440-70-2/Calcium; 9005-49-6/Heparin; EC 2.7.3.2/Creatine Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in uns...
Next Document:  Ketanserin inhibits depolarization-activated outward potassium current in rat ventricular myocytes.